FREE TOOL · LIVE DATA
NGNE DCF Calculator
Run your own discounted cash flow valuation for Neurogene Inc.. Enter the company data below and adjust assumptions to see fair value instantly.
SEARCH STOCK
Search to auto-fill real company data
COMPANY DATA
YOUR ASSUMPTIONS
YOUR DCF RESULT
CALCULATED FAIR VALUE
$236.67
MARKET
$26.08
YOUR DCF
$236.67
MARGIN
$210.59
VALUE BREAKDOWN
SENSITIVITY CHECK
Try adjusting growth rate by ±2% and discount rate by ±1% to see how sensitive your fair value is to assumptions.
COMPARE WITH FPI FAIR VALUE
Your DCF reflects your assumptions. As an independent reference, here is Fair Price Index's daily blended fair value for Neurogene Inc. — DCF (50%), relative valuation (30%), and analyst consensus (20%):
Frequently Asked Questions
What is NGNE's free cash flow?
Free cash flow data for Neurogene Inc. isn't available in our feed right now — enter it manually from the company's latest cash flow statement.
How do I calculate NGNE's fair value with a DCF?
Project Neurogene Inc.'s free cash flow forward at your assumed growth rate, discount each year back at your required return (WACC), add a terminal value, and divide by shares outstanding. The calculator above does all of this instantly as you adjust the assumptions.
What growth rate should I use for NGNE?
Anchor on history and sector reality: look at Neurogene Inc.'s revenue and cash flow growth over the past five to ten years, then ask what is sustainable going forward. Testing a conservative and an optimistic scenario matters more than any single number.
Is NGNE undervalued right now?
That depends on the assumptions you feed the model — that is the point of running your own DCF. For an independent reference, Fair Price Index publishes a daily fair value for Neurogene Inc. blending DCF, relative valuation, and analyst consensus.
GET ALERTS
Track NGNE's fair value daily
Download Fair Price Index and get notified when Neurogene Inc.'s valuation shifts.
Trusted by 500+ investors · Free tier available · PRO $2.99/month
RELATED
This calculator is for educational purposes only and does not constitute investment advice. Pre-filled figures come from the latest reported financials and may differ from other sources. Always verify against the company's filings.